# A Study of Single-dose MY008211A in Healthy Adults

> **NCT05642585** · PHASE1 · COMPLETED · sponsor: **Wuhan Createrna Science and Technology Co., Ltd** · enrollment: 63 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

- **DRUG:** MY008211A tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05642585
- **Lead sponsor:** Wuhan Createrna Science and Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-27
- **Primary completion:** 2023-06-04
- **Final completion:** 2023-06-04
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642585, "A Study of Single-dose MY008211A in Healthy Adults". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05642585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*